Search This Blog

Wednesday, August 7, 2019

Cara Therapeutics EPS beats by $0.03, beats on revenue

Cara Therapeutics (NASDAQ:CARA): Q2 GAAP EPS of -$0.58 beats by $0.03.
Revenue of $5.2M (+79.3% Y/Y) beats by $0.11M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)